title: Pharmaceutical Approval Update.
abstract: Coagulation factor IX (recombinant), albumin fusion protein (Idelvion) for hemophilia B; captisol-enabled melphalan hydrochloride (Evomela) for multiple myeloma; and antihemophilic factor (recombinant) (Kovaltry) for hemophilia A.
authors.forename: Mary
authors.initials: M
authors.lastname: Choy